SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001564590-21-057079
Filing Date
2021-11-15
Accepted
2021-11-15 17:26:58
Documents
77
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q/A qtnt-10qa_20210630.htm   iXBRL 10-Q/A 4152206
2 EX-31.1 qtnt-ex311_9.htm EX-31.1 16410
3 EX-31.2 qtnt-ex312_7.htm EX-31.2 16437
4 EX-32.1 qtnt-ex321_6.htm EX-32.1 5156
5 EX-32.2 qtnt-ex322_10.htm EX-32.2 5134
  Complete submission text file 0001564590-21-057079.txt   18548478

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA qtnt-20210630.xsd EX-101.SCH 55431
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE qtnt-20210630_cal.xml EX-101.CAL 75457
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE qtnt-20210630_def.xml EX-101.DEF 262424
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE qtnt-20210630_lab.xml EX-101.LAB 419363
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE qtnt-20210630_pre.xml EX-101.PRE 431611
11 EXTRACTED XBRL INSTANCE DOCUMENT qtnt-10qa_20210630_htm.xml XML 5547545
Mailing Address 28 ESPLANADE SAINT HELIER Y9 JE2 3QA
Business Address 28 ESPLANADE SAINT HELIER Y9 JE2 3QA 41274832286
Quotient Ltd (Filer) CIK: 0001596946 (see all company filings)

IRS No.: 264719797 | State of Incorp.: Y9 | Fiscal Year End: 0331
Type: 10-Q/A | Act: 34 | File No.: 001-36415 | Film No.: 211412708
SIC: 2835 In Vitro & In Vivo Diagnostic Substances